The Week in Review: Reckitt Benckiser Buys Anhui’s Golong Medicine
Reckitt Benckiser, a British maker of OTC drugs, acquired Golong Medicine of Anhui, a TCM company that will provide a base for Reckitt Benckiser’s products in China; China’s SFDA announced a set of newly-revised regulations for the country’s drug distributors to increase the safety of the drug supply chain; Sihuan Pharma received permission from the SFDA to begin clinical trials of an innovative treatment for type 2 diabetes; Regeneron Pharma and Bayer started a new Phase III of a treatment for Diabetic Macular Edema in China; Luye Pharma said its cholesterol-lowering TCM proved effective in a US Phase II clinical trial; and Beijing Double-Crane Pharma will invest $43 million to build a fluid infusion manufacturing facility in Shanghai’s Jinshan Development Park. More details…. Stock Symbols: (HK: 0460) (NSDQ: REGN) (Xetra: BAY) (SGX: A61) (SHE: 600062) Share this with colleagues: // //  
Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here